Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
132M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
1.34M
-
Shares change
-
-130M
-
Total reported value, excl. options
-
$10.7M
-
Value change
-
-$159M
-
Number of sells
-
-86
-
Price
-
$8.00
Significant Holders of RAPT Therapeutics, Inc. - Common Stock (RAPT) as of Q2 2025
89 filings reported holding RAPT - RAPT Therapeutics, Inc. - Common Stock as of Q2 2025.
RAPT Therapeutics, Inc. - Common Stock (RAPT) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.34M shares
of 132M outstanding shares and own 1.02% of the company stock.
Largest 10 shareholders include Column Group LLC (1.33M shares), AJU IB Investment Co., Ltd. (12.4K shares), EXCHANGE TRADED CONCEPTS, LLC (0 shares), NISA INVESTMENT ADVISORS, LLC (0 shares), Simplicity Wealth,LLC (0 shares), Callan Family Office, LLC (0 shares), Vanguard Personalized Indexing Management, LLC (0 shares), CWM, LLC (0 shares), WEALTH ENHANCEMENT ADVISORY SERVICES, LLC (0 shares), and Rise Advisors, LLC (0 shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.